ARTICLE | Company News
Intercell, SciGen Ltd. deal
December 20, 2004 8:00 AM UTC
Intercell and SIE will co-develop an HBV vaccine that combines SIE's Sci-B-Vac PreS1- and PreS2- HBV antigen with Intercell's Immunizer IC31 adjuvant. The companies will share development costs and wi...